SCPS (Scopus BioPharma) Other Current Liabilities: $0.09 Mil (As of Jun. 2023)


What is Scopus BioPharma Other Current Liabilities?

Scopus BioPharma SCPS Other Current Liabilities is $0.09 Mil as of Jun. 2023.

Scopus BioPharma's other current liabilities for the quarter that ended in Jun. 2023 was $0.09 Mil.

Scopus BioPharma's quarterly other current liabilities declined from Dec. 2022 ($0.25 Mil) to Mar. 2023 ($0.16 Mil) and declined from Mar. 2023 ($0.16 Mil) to Jun. 2023 ($0.09 Mil).

Scopus BioPharma's annual other current liabilities increased from Dec. 2020 ($-0.00 Mil) to Dec. 2021 ($0.00 Mil) and increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.25 Mil).

Scopus BioPharma Other Current Liabilities Related Terms

Scopus BioPharma Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Scopus BioPharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scopus BioPharma Other Current Liabilities Chart

Scopus BioPharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial 0.02 0.00 -0.00 0.00 0.25

Scopus BioPharma Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.25 0.16 0.09

Scopus BioPharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.09 Mil mean?
Scopus BioPharma (SCPS) has a Other Current Liabilities of $0.09 Mil as of Jun. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Scopus BioPharma.
Is Scopus BioPharma's Other Current Liabilities too high?
Scopus BioPharma's current Other Current Liabilities is $0.09 Mil.
How does Scopus BioPharma's Other Current Liabilities compare to AMPE and DRMA?
Scopus BioPharma's Other Current Liabilities of $0.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Scopus BioPharma. Scopus BioPharma's current Other Current Liabilities is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scopus BioPharma stock overvalued right now?
Scopus BioPharma (SCPS) has a current Other Current Liabilities of $0.09 Mil. The current Other Current Liabilities is $0.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Scopus BioPharma (SCPS), the current Other Current Liabilities is $0.09 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scopus BioPharma Business Description

Address 420 Lexington Avenue, Suite 300, New York, NY, USA, 10170
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.